Compound Summary
Compound Name: | 			3-DEAZAADENOSINE | 
Compound CID: | 			23190 | 
Synonyms: | 			3-DEAZAADENOSINE 6736-58-9 3-deaza-adenosine Deaza-Ado (2R,3R,4S,5R)-2-(4-Amino-1H-imidazo4,5-cpyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol More... | 
Iupac Name: | 			(2R,3R,4S,5R)-2-(4-aminoimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 
InChI: | 					InChI=1S/C11H14N4O4/c12-10-7-5(1-2-13-10)15(4-14-7)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1 | 
InChIKey: | 				DBZQFUNLCALWDY-PNHWDRBUSA-N | 
Canonical Smiles: | 		C1=CN=C(C2=C1N(C=N2)C3C(C(C(O3)CO)O)O)N | 
Isomeric Smiles: | 			C1=CN=C(C2=C1N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N | 
Molecular Weight: | 		266.25 | 
Molecular Formula: | 			C11H14N4O4 | 
Molecular Weight: | 		266.25 | 
Molecular Formula: | 			C11H14N4O4 | 
Hydrogen Bond Donor Count: | 			4 | 
Hydrogen Bond Acceptor Count: | 			7 | 
Rotatable Bond Count: | 			2 | 
Heavy Atom Count: | 					19 | 
Complexity: | 				334 | 
| 3-DEAZAADENOSINE | 3-DEAZAADENOSINE | 
|---|---|
3-DEAZAADENOSINE | 			
6736-58-9 | 
3-deaza-adenosine | 			
Deaza-Ado | 
(2R,3R,4S,5R)-2-(4-Amino-1H-imidazo4,5-cpyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | 			
UNII-037V4520IY | 
037V4520IY | 			
AD3 | 
3DZA | 			
NSC167897 | 
9-Deazaado | 			
3-Deaza Adenosine | 
DHCDA | 			
NSC 167897 | 
C^3Ado | 			
1hp0 | 
3-Deazaadenosine, 3-DeazaA | 			
BIDD:GT0703 | 
CHEMBL202701 | 			
GTPL5115 | 
SCHEMBL1738519 | 			
DTXSID2040941 | 
BDBM82055 | 			
2-CHLORO-5-IODONICOTINICACID | 
MFCD00153951 | 			
ZINC18193375 | 
CS-W014048 | 			
DB04546 | 
HY-W013332 | 			
NCGC00093846-07 | 
AC-32285 | 			
AS-78389 | 
CAS_6736-58-9 | 			
A852357 | 
J-700350 | 			
Q27073728 | 
1-beta-D-ribofuranosyl-1H-imidazo4,5-cpyridin-4-amine | 			
1-(beta-D-ribofuranosyl)-1H-imidazo4,5-cpyridin-4-amine | 
{1H-Imidazo4,5-cpyridine,} 4-amino-1-.beta.-D-ribofuranosyl- | 			
1H-Imidazo(4,5-c)pyridin-4-amine, 1-beta-D-ribofuranosyl- (9CI) | 
1H-Imidazo(4,5-c)pyridine, 4-amino-1-beta-D-ribofuranosyl- (8CI) | 			
(2R,3R,4S,5R)-2-(4-amino-1H-imidazo4,5-cpyridin-1-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol Hydrochloride;1-(beta-D-ribofuranosyl)-1H-imidazo4,5-cpyridin-4-amine Hydrochloride | 
(2R,3R,4S,5R)-2-(4-aminoimidazo4,5-cpyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | 			
(2R,3R,4S,5R)-2-{4-amino-1H-imidazo4,5-cpyridin-1-yl}-5-(hydroxymethyl)oxolane-3,4-diol | 
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 3.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 3.000000000000000 | 1 | 1 |